8 results on '"Brandt, Jason"'
Search Results
2. Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia.
- Author
-
Sanchez, Danielle L., Thomas, Kelsey R., Edmonds, Emily C., Bondi, Mark W., Bangen, Katherine J., Brandt, Jason, and Alzheimer’s Disease Neuroimaging Initiative
- Subjects
OLDER people ,ALZHEIMER'S disease ,COGNITION disorders ,DEMENTIA ,CEREBRAL circulation ,MILD cognitive impairment ,RESEARCH ,PREDICTIVE tests ,TIME ,RESEARCH methodology ,ACTIVITIES of daily living ,MAGNETIC resonance imaging ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,QUESTIONNAIRES ,LONGITUDINAL method - Abstract
Background: Increasing evidence indicates that cerebrovascular dysfunction may precede cognitive decline in aging and Alzheimer's disease (AD). Reduced cerebral blood flow (CBF) is associated with cognitive impairment in older adults. However, less is known regarding the association between CBF and functional decline, and whether CBF predicts functional decline beyond cerebrovascular and metabolic risk factors.Objective: To examine the association between regional CBF and functional decline in nondemented older adults.Method: One hundred sixty-six (N = 166) participants without dementia from the Alzheimer's Disease Neuroimaging Initiative underwent neuropsychological testing and neuroimaging. Pulsed arterial spin labeling magnetic resonance imaging was acquired to quantify resting CBF. Everyday functioning was measured using the Functional Assessment Questionnaire at baseline and annual follow-up visit across three years.Results: Adjusting for age, education, sex, cognitive status, depression, white matter hyperintensity volume, cerebral metabolism, and reference (precentral) CBF, linear mixed effects models showed that lower resting CBF at baseline in the medial temporal, inferior temporal, and inferior parietal lobe was significantly associated with accelerated decline in everyday functioning. Results were similar after adjusting for conventional AD biomarkers, including cerebrospinal fluid (CSF) amyloid-β (Aβ) and hyperphosphorylated tau (p-tau) and apolipoprotein E (APOE) ɛ4 positivity. Individuals who later converted to dementia had lower resting CBF in the inferior temporal and parietal regions compared to those who did not.Conclusion: Lower resting CBF in AD vulnerable regions including medial temporal, inferior temporal, and inferior parietal lobes predicted faster rates of decline in everyday functioning. CBF has utility as a biomarker in predicting functional declines in everyday life and conversion to dementia. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
3. Metabolic Syndrome and Cognitive Trajectories in the Framingham Offspring Study.
- Author
-
Bangen, Katherine J., Armstrong, Nicole M., Au, Rhoda, Gross, Alden L., and Brandt, Jason
- Subjects
METABOLIC syndrome ,ALZHEIMER'S disease ,NEUROPSYCHOLOGICAL tests ,COGNITIVE ability ,RESEARCH ,AGE distribution ,RESEARCH methodology ,COGNITION ,EVALUATION research ,MEDICAL cooperation ,SEX distribution ,COMPARATIVE studies ,SURVIVAL analysis (Biometry) ,APOLIPOPROTEINS ,RESEARCH funding ,SMOKING ,EDUCATIONAL attainment ,LONGITUDINAL method - Abstract
Metabolic syndrome (MetS) has been linked to increased risk of developing cognitive impairment and dementia including Alzheimer's disease. It remains unclear whether and at what stage in the adult lifespan MetS and its components begin to alter the trajectory of cognitive performance. In the present study, 2,892 Framingham Offspring participants completed health assessments every four years since 1971 and underwent repeat neuropsychological testing from 1999 to 2014. We estimated the associations of levels and changes in cognitive trajectories with hazard of MetS using a joint growth/survival model. All models were adjusted for baseline age, sex, education, and smoking status. Findings showed that both mid-life and late-life MetS were associated with lower level of cognitive functioning but not cognitive trajectories. Associations were strongest among those who were nondemented and apolipoprotein (APOE) ɛ4 noncarriers. In addition, individuals with the most rapid cognitive decline were more likely to have MetS. The pattern of results showed that associations between MetS and cognition varied, depending upon whether the sample was stratified by genetic and cognitive status and whether we considered cognitive performance as a continuous variable or examined categorical groupings. Given that mid-life MetS was associated with poorer cognition at age 55, cognitive changes may occur early during the MetS process. Our findings suggest that those with MetS are at greater risk of dementia given their lower level of cognitive functioning and also suggest that MetS may be a risk factor for decline in the absence of known risk factors including the APOEɛ4 allele. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
- Author
-
Alzheimer’s Disease Neuroimaging Initiative, Brandt, Jason, Thomas, Kelsey R., Edmonds, Emily C., Bondi, Mark W., Eppig, Joel, Salmon, David P., and Alzheimer’s Disease Neuroimaging Initiative
- Subjects
- *
MILD cognitive impairment , *NEUROPSYCHOLOGICAL tests , *ALZHEIMER'S disease , *DEMENTIA , *EARLY diagnosis , *DISEASE progression , *RESEARCH , *RESEARCH methodology , *EVALUATION research , *MEDICAL cooperation , *PSYCHOLOGICAL tests , *COMPARATIVE studies , *RESEARCH funding , *PROPORTIONAL hazards models , *DISEASE complications - Abstract
Background: We previously operationally-defined subtle cognitive decline (SCD) in preclinical Alzheimer's disease (AD) using total scores on neuropsychological (NP) tests. NP process scores (i.e., provide information about how a total NP score was achieved) may be a useful tool for identifying early cognitive inefficiencies prior to objective impairment seen in mild cognitive impairment (MCI) and dementia.Objective: We aimed to integrate process scores into the SCD definition to identify stages of SCD and improve early detection of those at risk for decline.Methods: Cognitively "normal" participants from the Alzheimer's Disease Neuroimaging Initiative were classified as "early" SCD (E-SCD; >1 SD below norm-adjusted mean on 2 process scores or on 1 process score plus 1 NP total score), "late" SCD (L-SCD; existing SCD criteria of >1 SD below norm-adjusted mean on 2 NP total scores in different domains), or "no SCD" (NC). Process scores considered in the SCD criteria were word-list intrusion errors, retroactive interference, and learning slope. Cerebrospinal fluid AD biomarkers were used to examine pathologic burden across groups.Results: E-SCD and L-SCD progressed to MCI 2.5-3.4 times faster than the NC group. Survival curves for E-SCD and L-SCD converged at 7-8 years after baseline. The combined (E-SCD+L-SCD) group had improved sensitivity to detect progression to MCI relative to L-SCD only. AD biomarker positivity increased across NC, SCD, and MCI groups.Conclusions: Process scores can be integrated into the SCD criteria to allow for increased sensitivity and earlier identification of cognitively normal older adults at risk for decline prior to frank impairment on NP total scores. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
5. Further Validation of the Internet-Based Dementia Risk Assessment
- Author
-
Brandt, Jason, primary, Blehar, Justin, additional, Anderson, Allan, additional, and Gross, Alden L., additional
- Published
- 2014
- Full Text
- View/download PDF
6. A New Algorithm for Predicting Time to Disease Endpoints in Alzheimer's Disease Patients
- Author
-
Razlighi, Qolamreza R., primary, Stallard, Eric, additional, Brandt, Jason, additional, Blacker, Deborah, additional, Albert, Marilyn, additional, Scarmeas, Nikolaos, additional, Kinosian, Bruce, additional, Yashin, Anatoliy I., additional, and Stern, Yaakov, additional
- Published
- 2013
- Full Text
- View/download PDF
7. A New Algorithm for Predicting Time to Disease Endpoints in Alzheimer's Disease Patients.
- Author
-
Razlighi, Qolamreza R., Stallard, Eric, Brandt, Jason, Blacker, Deborah, Albert, Marilyn, Scarmeas, Nikolaos, Kinosian, Bruce, Yashin, Anatoliy I., and Stern, Yaakov
- Subjects
ALZHEIMER'S patients ,CAREGIVERS ,CARE of people ,NEUROLOGY ,PUBLIC health - Abstract
Background: The ability to predict the length of time to death and institutionalization has strong implications for Alzheimer's disease patients and caregivers, health policy, economics, and the design of intervention studies. Objective: To develop and validate a prediction algorithm that uses data from a single visit to estimate time to important disease endpoints for individual Alzheimer's disease patients. Method: Two separate study cohorts (Predictors 1, N = 252; Predictors 2, N = 254), all initially with mild Alzheimer's disease, were followed for 10 years at three research centers with semiannual assessments that included cognition, functional capacity, and medical, psychiatric, and neurologic information. The prediction algorithm was based on a longitudinal Grade of Membership model developed using the complete series of semiannually-collected Predictors 1 data. The algorithm was validated on the Predictors 2 data using data only from the initial assessment to predict separate survival curves for three outcomes. Results: For each of the three outcome measures, the predicted survival curves fell well within the 95% confidence intervals of the observed survival curves. Patients were also divided into quintiles for each endpoint to assess the calibration of the algorithm for extreme patient profiles. In all cases, the actual and predicted survival curves were statistically equivalent. Predictive accuracy was maintained even when key baseline variables were excluded, demonstrating the high resilience of the algorithm to missing data. Conclusion: The new prediction algorithm accurately predicts time to death, institutionalization, and need for full-time care in individual Alzheimer's disease patients; it can be readily adapted to predict other important disease endpoints. The algorithm will serve an unmet clinical, research, and public health need. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Screening by Telephone in the Alzheimer's Disease Anti-inflammatory Prevention Trial.
- Author
-
Reckess, Gila Z., Brandt, Jason, Luis, Cheryl A., Zandi, Peter, Martin, Barbara, and Breitner, John C. S.
- Subjects
- *
ALZHEIMER'S disease research , *BASAL ganglia diseases , *ANTI-inflammatory agents , *ANTIPYRETICS , *DEMENTIA - Abstract
Compared with in-person assessment methods, telephone screening for dementia and other cognitive syndromes may improve efficiency of large population studies or prevention trials. We used data from the Alzheimer's Disease Anti-Inflammatory Prevention Trial to compare performance of a four-test Telephone Assessment Battery (TAB) that included the Telephone Interview for Cognitive Status (TICS) to that of a traditional in-person Cognitive Assessment Battery. Among 1,548 elderly participants with valid telephone and in-person screening results obtained within 90 days of each other, 225 persons were referred for a full cognitive diagnostic evaluation that was completed within six months of screening. Drawing on results from this panel of 225 individuals, we used the Capture-Recapture method to estimate population numbers of cognitively impaired participants. The latter estimates enabled us to compare the performance characteristics of the two screening batteries at specified cut-offs for detection of dementia and milder forms of impairment. Although our results provide relatively imprecise estimates of the performance characteristics of the two batteries, a comparison of their relative performance suggests that, at selected cut-off points, the TAB produces results broadly comparable to in-person screening and may be slightly more sensitive in detecting mild impairment. TAB performance characteristics also appeared slightly better than those of the TICS alone. Given its benefits in time and cost when screening for cognitive disorders, telephone screening should be considered for large samples. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.